About
Experts
Webinars & Conferences
Webinars
Conference recordings
External Webinars
Antimicrobial Viewpoints
Resources
Library
Antimicrobial Encyclopaedia
Conference calendar
JOIN US
Log in
Lost your password?
Create your account
My account
Logout
You are here
:
Home
-
Definition
Advanced search
Search our library
Use the filters below to narrow your search:
Content format
Article
Definition
Encyclopaedia
External resource
Video
Resource type
Antimicrobial Viewpoint
Conference
Database
Funding Mechanism
Guideline
Organization
Presentation
Project
Protocol/SOP
Publication
Scientific Journal
Tool
Video
Webinar
Drug development
CMC
Discovery
Exploratory
Hit-to-lead
Lead-to-candidate
Phase 1
Phase 2
Phase 3
Phase 4
PK/PD
Preclinical development
Regulatory
Screening
Toxicology
Indication
ABSSI
Bloodstream infection
Gonorrhoea
HAP/VAP
IAI
Pneumonia
SSTI
STI
Tuberculosis
UTI
Microbe / Microbial properties
Acinetobacter baumannii
Enterobacteriaceae
Enterococcus faecium
Escherichia coli
ESKAPE
Gram negative
Gram positive
Klebsiella pneumoniae
MDR
PDR
Pseudomonas aeruginosa
Staphylococcus aureus
WHO priority pathogens
XDR
Antibiotics class
Aminoglycosides
Carbapenems
Cephalosporins
Diarylquinolines
Glycopeptides
Lincomycins
Macrolides
Penicillins
Quinolones
Sulfonamides
Tetracyclines
Other tags
Access
Diagnostics
Stewardship
Search
Natural products
Adaptive trial
Phase 1, 2, 3, 4 trials
Clinical Development
Bacterial efflux
Therapeutic index
Minimum inhibitory concentration (MIC)
Maximum tolerated dose (MTD)
Investigational new drug (IND)
Pandrug-resistant (PDR)
Epidemiological cut-off value (ECOFF)
Breakpoint concentration, clinical
Pharmacokinetics-pharmacodynamics (PK/PD)
Lipophilicity
Tissue concentration
Intracellular concentration
Superiority trial
Preclinical development
Plasma protein binding
Plasma concentration
Median effective dose (ED50)
Antiseptic
Toxicity
Therapeutic window
Bacterial target
Target validation
Target product profile (TPP)
Target candidate profile (TCP)
Standard of care (SOC)
Septic shock
Sepsis
Antimicrobial resistance (AMR)
Randomized clinical trial (RCT)
Qualified infectious disease product (QIDP)
Pro-drug
Placebo-controlled trial
Pharmacovigilance
Non-inferiority margin
New drug application (NDA)
New chemical entity (NCE), new molecular entity (NME)
Medicinal chemistry
Median lethal dose (LD50)
Mechanism of action (MoA)
LogD
LogP
Lead compound
Hit-to-lead (HTL), lead generation
Hit identification, hit discovery
Hit confirmation, hit validation
High-throughput screen (HTS)
Extensively drug-resistant (XDR)
ESKAPE
Drug product, medicinal product
Chemistry, manufacturing and controls (CMC)
Cmax
Ames test
Absorption, distribution, metabolism, elimination (ADME)
Bactericidal
Antimicrobial susceptibility testing (AST), resistance testing
Antibiotic, antibacterial and antimicrobial
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our
cookie policy